Premature labour is the major cause of perinatal morbidity and mortality. The aetiology of most cases of preterm labour remains unknown. We tried to estimate whether immunological changes are present in patients with preterm labour. Fourteen patients with imminent preterm labour and 12 healthy women with uncomplicated pregnancies were included in the study. The specific lymphocyte antigens were determined using direct staining with monoclonal antibodies and analysed by flow cytometry. We observed that CD8+ lymphocyte percentage was significantly lower in the group of patients with preterm labour when compared to controls (p < 0.001). This deficit was related to T CD8+11b+ suppressor lymphocytes, while the percentage of T CD8+11b– cytotoxic lymphocytes did not differ in both studied groups. Furthermore, the percentage of T CD3+ lymphocytes was significantly lower and that of B CD19+ cells higher in the study group when compared to controls. Similarly, the percentage of CD4+45RA naive cells was higher in the group of patients with imminent preterm labour, while the percentage of memory CD4+45RO+ cells was lower in the study group in comparison with the control group. These observations suggest that alterations in maternal immunological parameters can be associated with the mechanisms mediating preterm labour.

Keywords:
Preterm labour, Flow cytometry, Lymphocytes
This content is only available via PDF.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.